Jasper Therapeutics, Inc. Derivative Liability
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2022-03-18
- 2021-06-30: Derivative Liability $10.43M.
- 2021-03-31: Derivative Liability $7.42M.
- 2020-12-31: Derivative Liability $8.16M; Derivative Liability as first filed $13.13M.
- 2019-12-31: Derivative Liability $7.24M.
| Period end | Derivative Liability | Derivative Liability as first filed |
|---|---|---|
| 2021-06-30 | $10.43M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $7.42M 10-Q · filed 2021-05-24 | |
| 2020-12-31 | $8.16M 10-K · filed 2022-03-18 | $13.13M 10-K/A · filed 2021-05-24 |
| 2019-12-31 | $7.24M 10-K/A · filed 2021-05-24 |